First FDA-approved treatment for preventing Ebola virusIn late December 2019, the U.S. Food and Drug Administration (FDA) announced the approval of Merck’s Ervebo, the first FDA-approved…
First targeted therapy for rare mutation of gastrointestinal stromal tumorsThe U.S. Food and Drug Administration (FDA) recently announced the approval of Blueprint Medicines Corporation’s avapritinib (Ayvakit) for the treatment…